MedTex Ventures

Axis Spine Technologies specializes in developing innovative spinal implants for anterior lumbar fixation. Founded in 2016, the company is headquartered in Hemel Hempstead, UK. Its flagship product is a modular fusion cage technology designed for atraumatic insertion, reducing risks associated with conventional implants.

Levita Magnetics SpA, established in January 2012 by Alberto Rodriguez-Navarro, is a medical device company based in Chile that focuses on advancing surgical techniques through its innovative magnetic surgical platform, Magnetic Surgery®. The company aims to enhance patient outcomes by promoting less invasive surgical procedures across various medical indications. Levita Magnetics has developed a unique magnetic surgical system that facilitates single and reduced port operations by utilizing non-traumatic, shaftless magnetic retraction. This approach eliminates the need for traditional trocars and shafted instruments, which can clutter the surgical field during procedures such as laparoscopic cholecystectomy. By minimizing surgical trauma and improving cosmetic results, Levita Magnetics is contributing to the evolution of modern surgery.

Based in Boston's biotech hub, Elucid improves cardiovascular diagnostic imaging via machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software for evaluating plaque vulnerability from a single CT scan to inform risk assessment and treatment selection.

Ictero Medical is a medical device company focused on developing minimally invasive solutions for gallbladder ablation, specifically targeting high-risk patients with gallstone disease. Their innovative tool is designed to operate within an interventional radiology suite, allowing for the defunctionalization of the gallbladder using only minimal local anesthesia. This approach offers physicians an alternative to traditional surgery, providing patients with the advantages of surgical treatment while mitigating associated risks. By prioritizing safety and efficacy, Ictero Medical aims to enhance patient care in the management of gallbladder conditions.

Based in Boston's biotech hub, Elucid improves cardiovascular diagnostic imaging via machine learning. Its flagship product, ElucidVivo, is the first FDA-cleared software for evaluating plaque vulnerability from a single CT scan to inform risk assessment and treatment selection.